Hjem › Eggstokkreft › New York › Buffalo
Kliniske studier for Eggstokkreft i Buffalo, NY
13 studier for Eggstokkreft søker deltakere på steder i og rundt Buffalo (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruttererFase 2
- Roswell Park Cancer Institute, Buffalo
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 2
- Roswell Park Cancer Institute IDS, Buffalo
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RekruttererFase 3
- Roswell Park Cancer Institute, Buffalo
GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer
RekruttererFase 1
- Roswell Park Comprehensive Cancer Center, Buffalo
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekruttererFase 1
- Roswell Park Comprehensive Cancer Center, Buffalo
Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer
RekruttererFase 2
- Roswell Park Cancer Institute, Buffalo
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RekruttererFase 1
- Roswell Park Comprehensive Care Center, Buffalo
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
RekruttererFase 1/2
- Roswell Park Cancer Institute, Buffalo
APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion
RekruttererFase 2
- Roswell Park Cancer Institute, Buffalo
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
RekruttererFase 1
- Roswell Park Cancer Institute, Buffalo
An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study
Rekrutterer
- Roswell Park Cancer Institute, Buffalo
A Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer
RekruttererFase 1
- Roswell Park, Buffalo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Buffalo
Eggstokkreft-studier i andre byer
- Houston, TX89 studier
- New York City, NY69 studier
- Boston, MA61 studier
- Los Angeles, CA50 studier
- Nashville, TN49 studier
- Arlington, VA46 studier
- Philadelphia, PA44 studier
- Columbus, OH39 studier
- St. Louis, MO38 studier
- Chicago, IL36 studier
- San Antonio, TX31 studier
- Cleveland, OH30 studier
Andre studier i Buffalo
- Ikke-småcellet lungekreft19 studier
- Kreft (alle typer)19 studier
- Akut myelogen leukemi19 studier
- Lungekreft16 studier
- Brystkreft16 studier
- Metastatisk kreft11 studier
- Prostatakreft11 studier
- Melanom10 studier
- Multipelt myelom10 studier
- Fedme9 studier
- Burkitts lymfom8 studier
- Myelodysplastiske syndromer8 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.